Treatment of Squamous Cell Carcinoma of the Nasal Cavity, Stage III or Stage IV
Clinical Scenario
This protocol addresses squamous cell carcinoma of the nasal cavity presenting at advanced stages. Stage III encompasses small to moderately advanced lesions, while stage IV involves more advanced disease. The majority of nasal cavity tumors are squamous cell carcinomas, and staging drives the selection of treatment strategy.
Disease Characteristics
Stage III and stage IV nasal cavity squamous cell carcinomas represent a spectrum from locally advanced to highly advanced disease. Accurate staging is central to determining whether locoregional therapies have an adequate response and whether systemic options need to be considered.
Treatment Approach (Overview)
When disease does not respond to radiation therapy or surgery, chemotherapy using combination drug regimens is an established consideration. The full protocol details the specific agents, combinations, sequencing, and decision criteria.
Complete regimen, dosing, and algorithm available in the full protocol →
References
- Nasal cavity tumors are squamous cell carcinomas.
- Stage III disease includes small and moderately advanced lesions.
- Stage IV disease includes advanced lesions.
- Chemotherapy should be considered for patients with disease that does not respond to radiation therapy or surgery.
- Various drug combinations, including cisplatin, fluorouracil, and methotrexate, are effective.
View source ↗